IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BEGHINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.397
EU - Europa 5.172
AS - Asia 4.101
SA - Sud America 431
AF - Africa 132
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.232
GB - Regno Unito 2.026
CN - Cina 1.277
SG - Singapore 1.170
IT - Italia 825
SE - Svezia 453
RU - Federazione Russa 452
DE - Germania 430
VN - Vietnam 362
BR - Brasile 329
HK - Hong Kong 307
IN - India 221
FR - Francia 213
BD - Bangladesh 145
TR - Turchia 143
NL - Olanda 139
KR - Corea 127
UA - Ucraina 115
FI - Finlandia 111
JP - Giappone 106
IE - Irlanda 105
CA - Canada 99
ID - Indonesia 87
DK - Danimarca 62
EU - Europa 58
CI - Costa d'Avorio 47
ES - Italia 46
TN - Tunisia 35
AR - Argentina 34
GR - Grecia 34
MX - Messico 32
PL - Polonia 25
CH - Svizzera 22
BE - Belgio 21
CO - Colombia 21
ZA - Sudafrica 19
AU - Australia 16
CZ - Repubblica Ceca 16
IQ - Iraq 16
NO - Norvegia 15
AT - Austria 14
RO - Romania 14
IR - Iran 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
CL - Cile 10
EC - Ecuador 10
NP - Nepal 10
PK - Pakistan 10
UZ - Uzbekistan 10
JM - Giamaica 9
VE - Venezuela 9
EG - Egitto 8
PH - Filippine 8
IL - Israele 7
MA - Marocco 7
PY - Paraguay 7
KZ - Kazakistan 6
MY - Malesia 6
PT - Portogallo 6
TW - Taiwan 6
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RS - Serbia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
QA - Qatar 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DZ - Algeria 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
TH - Thailandia 3
BG - Bulgaria 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
SV - El Salvador 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 15.294
Salva come PNG Salva come JPEG
Città #
Southend 1.872
Singapore 706
Ashburn 595
Boise 538
Milan 341
Chandler 287
Hong Kong 259
San Jose 249
Seattle 241
Beijing 235
Fairfield 217
Wilmington 167
Council Bluffs 166
Princeton 139
Woodbridge 137
Dearborn 123
Frankfurt am Main 122
Ann Arbor 110
Ho Chi Minh City 110
Houston 107
Dublin 105
New York 95
Dallas 94
Cambridge 90
Los Angeles 89
Hanoi 84
Hefei 84
Nanjing 82
Redmond 76
Bengaluru 75
Lauterbourg 71
Mountain View 70
Redwood City 68
Guangzhou 67
Jacksonville 66
Jakarta 66
Moscow 63
Buffalo 61
Santa Clara 60
Des Moines 49
Sakarya 48
Abidjan 47
Tokyo 46
Shanghai 44
Boardman 43
Phoenix 39
São Paulo 37
Saint Petersburg 36
Columbus 35
Seoul 34
Toronto 34
Athens 33
Helsinki 33
Garden Valley 32
Tianjin 32
Hangzhou 29
Jerome 27
Andover 26
Payette 26
Tunis 26
Berlin 25
Munich 25
The Dalles 25
Cangzhou 23
Lewiston 23
Shenzhen 23
Hanover 22
Chicago 21
Da Nang 21
Changsha 20
Jinan 20
Cottonwood 19
Eitensheim 19
Rome 19
Serra 19
Turku 19
Bogotá 18
Concorezzo 18
Hebei 18
Nanchang 18
San Diego 18
Shenyang 18
Madrid 17
Haiphong 16
Turin 16
Brussels 15
Rio de Janeiro 15
Atlanta 14
Brugherio 14
Bühl 14
Chengdu 14
Grafing 14
Kent 14
London 14
Melegnano 14
Roxbury 14
Orofino 13
Wuhan 13
Bologna 12
Fino Mornasco 12
Totale 9.649
Salva come PNG Salva come JPEG
Nome #
STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade 756
KIT activating mutations : incidence in adult and pediatric AML, and identification of an internal tandem duplication 697
Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis 495
FZD6 triggers Wnt-signalling driven by WNT10BIVS1 expression and highlights new targets in T cell acute lymphoblastic leukemia 425
Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta. 331
FZD6 (Frizzled class receptor 6) 326
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index 325
An unusual mutation in RECQ4 gene leading to Rothmund-Thomson syndrome 316
Identification of kitM541l somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response 309
FZD4 (frizzled class receptor 4) 305
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia (Scientific Reports (2017) 6 (37201) DOI: 10.1038/srep37201) 296
Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. 290
Core Binding Factor Leukemia : Chromatin Remodeling Moves Towards Oncogenic Transcription 270
A novel start‐loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms 257
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia 253
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations - A report of three cases 252
The Kasumi-1 cell line : a t(8;21)-kit mutant model for acute myeloid leukemia 244
Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits 244
WNT10B (Wingless-Type MMTV Integration Site Family) 243
Clinical relevance of recurrent allele-specific recombination expressing the WNT10Bivs1 allele variant in acute myeloid leukemia 235
Targeting WNT10B-Driven Signalling through Induction of FZD6 By Porcupine Inhibition in T Cell Acute Lymphoblastic Leukemia 233
Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses. [Erratum to document cited in CA144:085286] 231
PTPN6 (protein tyrosine phosphatase, non-receptor type 6) 230
Regeneration-associated Wnt signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells 222
The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines 220
Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia 214
An algorithm to assess the reliability of hierarchical clusters in gene expression data 202
Prognostic impact of c-KIT mutations in core binding factor leukemias. an Italian retrospective study 202
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells 202
Molecular screening of PDGFRA and PDGFRB genes in KIT and FLT3 negative core binding factor leukemias 201
Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement 199
A stability-based algorithm to validate hierarchical clusters of genes 196
Distinct expression pattern of microtubule-associated protein/microtubule affinity-regulating kinase 4 in differentiated neurons 187
Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence 183
A mathematical model for the validation of gene selection methods 180
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia 176
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorfism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation 174
Rothmund-Thomson syndrome (RTS) 173
Familial / sporadic gastrointestinal stromal tumors (GISTs) 171
PTPN13 (Protein tyrosine phosphatase, nonreceptor type 13) 170
+4 or trisomy 4 168
Identification of two novel RECQL4exonic SNPs and genomic characterization of the IVS12 minisatellite 164
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 162
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) 161
Molecular events in acute myeloid leukemogenesis: a model from core binding factor leukemia 160
Prevalence and prognostic impact of KIT mutations in acute myeloid leukaemia with inv(16). A retrospective study 159
RNA processing defects of the helicase gene RECQL4 in a compound heterozygous Rothmund-Thomson patient 157
IMPACT OF KIT MUTATIONS IN ACUTE MYELOID LEUKAEMIA WITH INV(16) 154
Prognostic impact of C-KIT mutations in Core Binding Factor-Leukemia 153
C-kit mutations in core binding factor leukemias 145
c-kit activating mutations and mast cell proliferation in human leukemia 144
Germline mutation in the juxtamembrane domain of KIT gene in a family with GISTs and Urticaria Pigmentosa 144
Total serum tryptase : a predictive marker for KIT mutation in acute myeloid leukemia 143
Serum tryptase levels in AML at diagnosis : a multicenter retrospective study 142
Piebaldism 140
Carbonic Anhydrase 9: mastering ferropoptosis resistance in cancer, protector or weak point? 137
MARK4 (MAP/microtubule affinity-regulating kinase 4) 134
KIT mutations in core binding factor leukemias: outcome prediction and therapeutic implications 133
AML with t(8;21) and trisomy 4: possible involvement of c-kit? 131
Systemic mast cell disease 130
Common Gene Expression Signature of B-Cells of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathies of Undetermined Significance (IgM MGUS) Compared to Healthy Subjects 129
KITLG (KIT ligand) 122
RECQL4 (RecQ protein-like 4) 121
Prognostic markers in AML : focus on CBFL 118
Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified 118
Beyond the Warburg Effect: KRAS/MAPK-Driven Uridine Utilization in Glucose-Deprived Pancreatic Ductal Adenocarcinoma 116
High frequency of c-kit mutation in core binding factor leukemia 116
Efficacy of Midostaurin Combined with Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial 114
Primary hypereosinophilic sindromes and imatinib therapy: a rtrospective analysis of 38 cases 111
KITLG (KIT ligand) 108
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects 106
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 106
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation 104
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation 101
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 95
Genetic Landscape and Clonal Evolution Patterns of CEBPA-Mutated Acute Myeloid Leukaemia Based on NextGeneration Sequencing: A Retrospective Analysis 95
Bloom syndrome 93
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 89
CSNK2A2 (casein kinase 2 alpha 2) 88
Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results 72
null 3
Totale 15.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 0 0 0 0 0 265 105
2021/20221.086 110 87 52 84 111 58 96 72 83 87 81 165
2022/20231.207 143 140 98 138 139 202 31 104 106 22 45 39
2023/2024993 22 51 51 41 185 51 55 276 22 48 81 110
2024/20252.058 75 196 50 204 152 118 101 221 103 158 184 496
2025/20264.152 348 295 372 424 429 288 565 239 424 343 425 0
Totale 15.921